Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H13N3OS |
Molecular Weight | 307.37 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)C2=CN3N=CC(C4=CSC=C4)=C3N=C2
InChI
InChIKey=HBWLNACPIFKNIP-UHFFFAOYSA-N
InChI=1S/C17H13N3OS/c1-21-15-4-2-12(3-5-15)14-8-18-17-16(9-19-20(17)10-14)13-6-7-22-11-13/h2-11H,1H3
Molecular Formula | C17H13N3OS |
Molecular Weight | 307.37 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics. | 2002 Dec 16 |
|
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. | 2011 Oct 30 |
|
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. | 2013 Apr 15 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:04:08 GMT 2023
by
admin
on
Sat Dec 16 08:04:08 GMT 2023
|
Record UNII |
FHX0K077F6
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
216661-57-3
Created by
admin on Sat Dec 16 08:04:08 GMT 2023 , Edited by admin on Sat Dec 16 08:04:08 GMT 2023
|
PRIMARY | |||
|
DTXSID90416191
Created by
admin on Sat Dec 16 08:04:08 GMT 2023 , Edited by admin on Sat Dec 16 08:04:08 GMT 2023
|
PRIMARY | |||
|
FHX0K077F6
Created by
admin on Sat Dec 16 08:04:08 GMT 2023 , Edited by admin on Sat Dec 16 08:04:08 GMT 2023
|
PRIMARY | |||
|
5329468
Created by
admin on Sat Dec 16 08:04:08 GMT 2023 , Edited by admin on Sat Dec 16 08:04:08 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |